Literature DB >> 16758355

Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats.

Tufan Hicdonmez1, Mehmet Kanter, Mehmet Tiryaki, Turgay Parsak, Sebahattin Cobanoglu.   

Abstract

N-acetylcysteine (NAC) is a precursor of glutathione, a potent antioxidant, and a free radical scavenger. The beneficial effect of NAC on nervous system ischemia and ischemia/reperfusion models has been well documented. However, the effect of NAC on nervous system trauma remains less understood. Therefore, we aimed to investigate the therapeutic efficacy of NAC with an experimental closed head trauma model in rats. Thirty-six adult male Sprague-Dawley rats were randomly divided into three groups of 12 rats each: Group I (control), Group II (trauma-alone), and Group III (trauma+NAC treatment). In Groups II and III, a cranial impact was delivered to the skull from a height of 7 cm at a point just in front of the coronal suture and over the right hemisphere. Rats were sacrificed at 2 h (Subgroups I-A, II-A, and III-A) and 12 h (Subgroups I-B, II-B, and III-B) after the onset of injury. Brain tissues were removed for biochemical and histopathological investigation. The closed head trauma significantly increased tissue malondialdehyde (MDA) levels (P < 0.05), and significantly decreased tissue superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities (P < 0.05), but not tissue catalase (CAT) activity, when compared with controls. The administration of a single dose of NAC (150 mg/kg) 15 min after the trauma has shown protective effect via decreasing significantly the elevated MDA levels (P < 0.05) and also significantly (P < 0.05) increasing the reduced antioxidant enzyme (SOD and GPx) activities, except CAT activity. In the trauma-alone group, the neurons became extensively dark and degenerated into picnotic nuclei. The morphology of neurons in the NAC treatment group was well protected. The number of neurons in the trauma-alone group was significantly less than that of both the control and trauma+NAC treatment groups. In conclusion, the NAC treatment might be beneficial in preventing trauma-induced oxidative brain tissue damage, thus showing potential for clinical implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758355     DOI: 10.1007/s11064-006-9040-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  64 in total

Review 1.  Caspases and caspase inhibitors.

Authors:  P Villa; S H Kaufmann; W C Earnshaw
Journal:  Trends Biochem Sci       Date:  1997-10       Impact factor: 13.807

2.  Caspase-3 mediated neuronal death after traumatic brain injury in rats.

Authors:  R S Clark; P M Kochanek; S C Watkins; M Chen; C E Dixon; N A Seidberg; J Melick; J E Loeffert; P D Nathaniel; K L Jin; S H Graham
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

3.  Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study.

Authors:  Jia Lu; Shabbir Moochhala; Md Shirhan; Kian Chye Ng; Ai Ling Teo; Mui Hong Tan; Xiao Lei Moore; Meng Cheong Wong; Eng Ang Ling
Journal:  Neuropharmacology       Date:  2003-02       Impact factor: 5.250

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  A simple method for clinical assay of superoxide dismutase.

Authors:  Y Sun; L W Oberley; Y Li
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

Review 6.  N-acetylcysteine in acute cardiology: 10 years later: what do we know and what would we like to know?!

Authors:  Jan Sochman
Journal:  J Am Coll Cardiol       Date:  2002-05-01       Impact factor: 24.094

7.  Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats.

Authors:  Ibolja Cernak; Sarah M Chapman; Gary P Hamlin; Robert Vink
Journal:  J Clin Neurosci       Date:  2002-09       Impact factor: 1.961

8.  The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid.

Authors:  O I Aruoma; B Halliwell; B M Hoey; J Butler
Journal:  Free Radic Biol Med       Date:  1989       Impact factor: 7.376

9.  Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Bipanjeet Sekhon; Manu Jatana; Shailendra Giri; Anne G Gilg; Charanpal Sekhon; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2004-05-15       Impact factor: 4.164

10.  N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells.

Authors:  G Ferrari; C Y Yan; L A Greene
Journal:  J Neurosci       Date:  1995-04       Impact factor: 6.167

View more
  32 in total

1.  The cysteine-rich whey protein supplement, Immunocal®, preserves brain glutathione and improves cognitive, motor, and histopathological indices of traumatic brain injury in a mouse model of controlled cortical impact.

Authors:  Elizabeth Ignowski; Aimee N Winter; Nathan Duval; Holly Fleming; Tyler Wallace; Evan Manning; Lilia Koza; Kendra Huber; Natalie J Serkova; Daniel A Linseman
Journal:  Free Radic Biol Med       Date:  2018-06-27       Impact factor: 7.376

Review 2.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

3.  Neuroprotective effects of caffeic acid phenethyl ester on experimental traumatic brain injury in rats.

Authors:  Memduh Kerman; Mehmet Kanter; Kerim Kenan Coşkun; Mustafa Erboga; Ahmet Gurel
Journal:  J Mol Histol       Date:  2011-11-29       Impact factor: 2.611

4.  N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.

Authors:  Jignesh D Pandya; Ryan D Readnower; Samir P Patel; Heather M Yonutas; James R Pauly; Glenn A Goldstein; Alexander G Rabchevsky; Patrick G Sullivan
Journal:  Exp Neurol       Date:  2014-05-01       Impact factor: 5.330

Review 5.  Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.

Authors:  Hanna Deselms; Nicola Maggio; Vardit Rubovitch; Joab Chapman; Shaul Schreiber; David Tweedie; Dong Seok Kim; Nigel H Greig; Chaim G Pick
Journal:  J Neurosci Methods       Date:  2016-02-08       Impact factor: 2.390

6.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

7.  Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats.

Authors:  Samah G Abdel Baki; Ben Schwab; Margalit Haber; André A Fenton; Peter J Bergold
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

8.  Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.

Authors:  Ziyan Zhang; Jingqi Yan; Saeid Taheri; Ke Jian Liu; Honglian Shi
Journal:  Free Radic Biol Med       Date:  2013-12-01       Impact factor: 7.376

9.  Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC).

Authors:  Hao-Ran Qian; Yi Yang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

Review 10.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.